PO Box
1948
Eldoret, 30100
Kenya
Moi University
HIV, adolescents, cabotegravir and rilpivirine, antiretroviral therapy, injectable, clinical trial
HIV, adolescents, dolutegravir, short cycle therapy, young people, randomised controlled trial
ICU mortality, Predictive models, APACHE II, Rwanda MPM, MPM0 III